PROVECTUS BIOPHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of 0.00% for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2016-03-30
- PROVECTUS BIOPHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2015 was 0.00%.
- PROVECTUS BIOPHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2014 was 0.00%.
- PROVECTUS BIOPHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2013 was 0.00%, a 100.00% decline from fiscal 2012.
- PROVECTUS BIOPHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2012 was 7.00%, a 26.32% decline from fiscal 2011.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month |
|---|---|
| 2015-12-31 | 0.00% 10-K · filed 2016-03-30 |
| 2014-12-31 | 0.00% 10-K · filed 2016-03-30 |
| 2013-12-31 | 0.00% 10-K · filed 2016-03-30 |
| 2012-12-31 | 7.00% 10-K · filed 2015-03-12 |
| 2011-12-31 | 9.50% 10-K · filed 2014-03-13 |
| 2010-12-31 | 10.00% 10-K · filed 2013-03-14 |